Chrono CEO Alan Levy Retires, David Happel Named New Chief Executive

Alan Levy, CEO and chairman of Chrono Therapeutics, is retiring. The Hayward, CA, company said Levy will remain on the board of directors. David Happel has been appointed CEO, and current board member James Young will take on the role of board chairman. Happel comes to Chrono from Horizon Pharma (NASDAQ: [[ticker:HZNP]]), where he was executive vice president of commercial development and strategy. Chrono has developed an experimental “smart” drug delivery technology that administers nicotine at peak craving times to help smokers quit.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.